{"DataElement":{"publicId":"5214798","version":"1","preferredName":"Anesthetic Agent Intravenous Administration Name","preferredDefinition":"The name of the anesthetic agent administered within or into a vein or veins prior to organ removal in order to produce a loss of feeling.","longName":"ANESTH_IV_NAME","context":"BBRB","contextVersion":"1","DataElementConcept":{"publicId":"5211137","version":"1","preferredName":"Anesthetic Agent Intravenous Administration","preferredDefinition":"A drug or other substance that causes a loss of feeling or awareness. Local anesthetics cause a loss of feeling in one small area of the body. Regional anesthetics cause a loss of feeling in a part of the body, such as an arm or leg. General anesthetics cause a loss of feeling and a complete loss of awareness that feels like a very deep sleep._Into or within a vein. Intravenous usually refers to a way of giving a drug or other substance through a needle or tube inserted into a vein._The act of the dispensing, applying, or tendering of something to another, such as administration of a medicine.","longName":"2704979v1.0:2717633v1.0","context":"BBRB","contextVersion":"1","ObjectClass":{"publicId":"2704979","version":"1","preferredName":"Anesthetic Agent","preferredDefinition":"(an-es-THET-iks) Substances that cause loss of feeling or awareness. Local anesthetics cause loss of feeling in a part of the body. General anesthetics put the person to sleep.","longName":"C245","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anesthetic Agent","conceptCode":"C245","definition":"A pharmacological agent that acts in a reversible fashion and can be applied either locally or systemically to cause a partial or total loss of sensation and pain or to induce unconsciousness.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"405AB8C8-7B39-15EC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-12-03","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-12-03","modifiedBy":"ONEDATA","dateModified":"2007-12-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2717633","version":"1","preferredName":"Intravenous Administration","preferredDefinition":"(in-tra-VEE-nus) IV. Within a blood vessel.:The act of administration.","longName":"C13346:C25409","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intravenous","conceptCode":"C13346","definition":"Into or within a vein. Intravenous usually refers to a way of giving a drug or other substance through a needle or tube inserted into a vein.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Administration","conceptCode":"C25409","definition":"The act of the dispensing, applying, or tendering of something to another, such as administration of a medicine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42624FF7-0150-68FE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-12-28","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2007-12-28","modifiedBy":"ONEDATA","dateModified":"2007-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435024","version":"1","preferredName":"Drug or Chemical","preferredDefinition":"A category of organic or inorganic substances, elements, and isotopes used in research or for the prevention, diagnosis, and/or treatment of disease states. Includes biologically active substances that are either synthetically manufactured or endogenous substances extracted and processed to be reintroduced into an organism. Chemicals and drugs also include hazardous substances, and naturally occurring or synthetically produced substances required to maintain life.","longName":"C1908","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"07431EBC-FB04-25D9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"BPV: Biospecimen Pre-analytical Variables (BPV) Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FC9BDDD-32B8-501F-E050-BB89AD434E5A","latestVersionIndicator":"Yes","beginDate":"2016-04-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-06","modifiedBy":"HARTLEYG","dateModified":"2016-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5212045","version":"1","preferredName":"Intravenous Anesthetic Agent Name","preferredDefinition":"The words or language units by which a thing is known.","longName":"5212045v1.0","context":"BBRB","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other IV Anesthesia Agents (specify)","valueDescription":"Other","ValueMeaning":{"publicId":"2946060","version":"1","preferredName":"Other","longName":"2946060","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746A8063-D650-3C9D-E040-BB89AD437A9B","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"1/25/23 added alt name for ticket number CADSR0001948 for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FD7CF95-9433-38AC-E050-BB89AD436C35","beginDate":"2016-04-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-06","modifiedBy":"ONEDATA","dateModified":"2016-04-06","deletedIndicator":"No"},{"value":"Propofol","valueDescription":"Propofol","ValueMeaning":{"publicId":"5212049","version":"1","preferredName":"Propofol","longName":"5212049","preferredDefinition":"A hypnotic alkylphenol derivative. Formulated for intravenous induction of sedation and hypnosis during anesthesia, propofol facilitates inhibitory neurotransmission mediated by gamma-aminobutyric acid (GABA). This agent is associated with minimal respiratory depression and has a short half-life with a duration of action of 2 to 10 minutes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Propofol","conceptCode":"C29384","definition":"A hypnotic alkylphenol derivative. Formulated for intravenous induction of sedation and hypnosis during anesthesia, propofol facilitates inhibitory neurotransmission mediated by gamma-aminobutyric acid (GABA). This agent is associated with minimal respiratory depression and has a short half-life with a duration of action of 2 to 10 minutes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FD7CF95-9466-38AC-E050-BB89AD436C35","latestVersionIndicator":"Yes","beginDate":"2016-04-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-06","modifiedBy":"COOPERM","dateModified":"2019-11-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FD7CF95-947F-38AC-E050-BB89AD436C35","beginDate":"2016-04-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-06","modifiedBy":"ONEDATA","dateModified":"2016-04-06","deletedIndicator":"No"},{"value":"Ketamine","valueDescription":"Ketamine","ValueMeaning":{"publicId":"5212051","version":"1","preferredName":"Ketamine","longName":"5212051","preferredDefinition":"A cyclohexanone derivative with analgesic and anesthetic properties. Although its mechanism of action is not well understood, ketamine appears exerts complex pharmacological actions including inhibition of biogenic amine uptake, binding to opioid receptors, and inhibition of N-methyl D-aspartate (NMDA) receptors. Because of the involvement of spinal NMDA receptors in the process of central sensitization, this agent may reduce pain perception and induce sedation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ketamine","conceptCode":"C61797","definition":"A cyclohexanone derivative with analgesic and anesthetic properties. Although its mechanism of action is not well understood, ketamine appears exerts complex pharmacological actions including inhibition of biogenic amine uptake, binding to opioid receptors, and inhibition of N-methyl D-aspartate (NMDA) receptors. Because of the involvement of spinal NMDA receptors in the process of central sensitization, this agent may reduce pain perception and induce sedation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FD7CF95-948C-38AC-E050-BB89AD436C35","latestVersionIndicator":"Yes","beginDate":"2016-04-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FD7CF95-94A5-38AC-E050-BB89AD436C35","beginDate":"2016-04-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-06","modifiedBy":"ONEDATA","dateModified":"2016-04-06","deletedIndicator":"No"},{"value":"Etomidate","valueDescription":"Etomidate","ValueMeaning":{"publicId":"2576837","version":"1","preferredName":"Etomidate","longName":"2576837","preferredDefinition":"An imidazole derivative with short-acting sedative, hypnotic, and general anesthetic properties. Etomidate appears to have gamma-aminobutyric acid (GABA) like effects, mediated through GABA-A receptor. The action enhances the inhibitory effect of GABA on the central nervous system by causing chloride channel opening events which leads to membrane hyperpolarization.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Etomidate","conceptCode":"C47527","definition":"An imidazole derivative with short-acting sedative, hypnotic, and general anesthetic properties. Etomidate appears to have gamma-aminobutyric acid (GABA) like effects, mediated through GABA-A receptor. The action enhances the inhibitory effect of GABA on the central nervous system by causing chloride channel opening events which leads to membrane hyperpolarization.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F932-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-11-08","modifiedBy":"COOPERM","dateModified":"2019-08-06","changeDescription":"Updated concept definition. mc 8.6.19","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FD7CF95-94AF-38AC-E050-BB89AD436C35","beginDate":"2016-04-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-06","modifiedBy":"ONEDATA","dateModified":"2016-04-06","deletedIndicator":"No"},{"value":"Brevital","valueDescription":"Methohexital","ValueMeaning":{"publicId":"5227211","version":"1","preferredName":"Methohexital","longName":"5227211","preferredDefinition":"A rapid, short-acting barbituric acid derivative, with anesthetic activity. Methohexital binds to the chloride ionophore site of the gamma-aminobutyric acid (GABA)-A/chloride ionophore receptor complex, thereby enhancing the inhibitory actions of GABA-A in the brain. This leads to synaptic inhibition, decreased neuronal excitability, and induction of anesthesia. In addition, this agent decreases glutamate (Glu) responses.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Methohexital","conceptCode":"C66116","definition":"A rapid, short-acting barbituric acid derivative, with anesthetic activity. Methohexital binds to the chloride ionophore site of the gamma-aminobutyric acid (GABA)-A/chloride ionophore receptor complex, thereby enhancing the inhibitory actions of GABA-A in the brain. This leads to synaptic inhibition, decreased neuronal excitability, and induction of anesthesia. In addition, this agent decreases glutamate (Glu) responses.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"30CC0AAE-1882-8EE5-E050-BB89AD433C11","latestVersionIndicator":"Yes","beginDate":"2016-04-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"30CC0AAE-189B-8EE5-E050-BB89AD433C11","beginDate":"2016-04-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-18","modifiedBy":"ONEDATA","dateModified":"2016-04-18","deletedIndicator":"No"},{"value":"Sodium Thiopental","valueDescription":"Thiopental Sodium","ValueMeaning":{"publicId":"5227212","version":"1","preferredName":"Thiopental Sodium","longName":"5227212","preferredDefinition":"The sodium salt form of thiopental, an ultrashort-acting barbituric acid derivative, with anesthetic activity. Thiopental binds to the chloride ionophore site of the gamma-aminobutyric acid (GABA)-A/chloride ionophore receptor complex, thereby enhancing the inhibitory actions of GABA-A in the brain. This leads to synaptic inhibition, decreased neuronal excitability and induction of anesthesia. In addition, this agent decreases glutamate (Glu) responses.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thiopental Sodium","conceptCode":"C66599","definition":"The sodium salt form of thiopental, an ultrashort-acting barbituric acid derivative, with anesthetic activity. Thiopental binds to the chloride ionophore site of the gamma-aminobutyric acid (GABA)-A/chloride ionophore receptor complex, thereby enhancing the inhibitory actions of GABA-A in the brain. This leads to synaptic inhibition, decreased neuronal excitability and induction of anesthesia. In addition, this agent decreases glutamate (Glu) responses.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"30CC0AAE-18A5-8EE5-E050-BB89AD433C11","latestVersionIndicator":"Yes","beginDate":"2016-04-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"30CC0AAE-18BD-8EE5-E050-BB89AD433C11","beginDate":"2016-04-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-18","modifiedBy":"ONEDATA","dateModified":"2016-04-18","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435024","version":"1","preferredName":"Drug or Chemical","preferredDefinition":"A category of organic or inorganic substances, elements, and isotopes used in research or for the prevention, diagnosis, and/or treatment of disease states. Includes biologically active substances that are either synthetically manufactured or endogenous substances extracted and processed to be reintroduced into an organism. Chemicals and drugs also include hazardous substances, and naturally occurring or synthetically produced substances required to maintain life.","longName":"C1908","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"07431EBC-FB04-25D9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2229718","version":"1","preferredName":"Name","preferredDefinition":"The words or language units by which a thing is known.","longName":"C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F6EF4E2B-76AE-72C1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-16","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-05-16","modifiedBy":"ONEDATA","dateModified":"2005-05-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"BPV: Biospecimen Pre-analytical Variables (BPV) Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FD7CF95-9413-38AC-E050-BB89AD436C35","latestVersionIndicator":"Yes","beginDate":"2016-04-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-06","modifiedBy":"HARTLEYG","dateModified":"2016-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5188870","version":"1","longName":"BPV - Tumor Biospecimen Acquisition","context":"BBRB","ClassificationSchemeItems":[{"publicId":"5405791","version":"1","longName":"BPV - Tumor Biospecimen Acquisition","context":"BBRB"},{"publicId":"6736433","version":"1","longName":"Kidney Surgery-Anesthesia","context":"BBRB"},{"publicId":"6736434","version":"1","longName":"Lung Surgery-Anesthesia","context":"BBRB"},{"publicId":"6736432","version":"1","longName":"Colon Surgery-Anesthesia","context":"BBRB"},{"publicId":"6736435","version":"1","longName":"Ovary Sugery-Anesthesia","context":"BBRB"}]}],"AlternateNames":[{"name":"BBRB","type":"USED_BY","context":"BBRB"}],"ReferenceDocuments":[{"name":"IV Anesthesia Agents","type":"Preferred Question Text","description":"IV Anesthesia Agents","url":null,"context":"BBRB"}],"origin":"BPV: Biospecimen Pre-analytical Variables (BPV) Program","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"2FDECFC9-855C-D6FE-E050-BB89AD437E75","latestVersionIndicator":"Yes","beginDate":"2016-04-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-07","modifiedBy":"HARTLEYG","dateModified":"2019-04-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}